4.2 Review

Therapeutic Approaches for Peripheral and Central Neuropathic Pain

期刊

BEHAVIOURAL NEUROLOGY
卷 2019, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2019/8685954

关键词

-

资金

  1. Economic Development and Innovation Operational Program (Gazdasagfejlesztesi es Innovacios Operativ Program) - European Union [GINOP-2.3.2-15-2016-00034]
  2. MTA-SZTE Neuroscience Research Group of the Hungarian Academy of Sciences
  3. University of Szeged
  4. Ministry of Human Capacities, Hungary [20391-3/2018/FEKUSTRAT]

向作者/读者索取更多资源

Neuropathic pain is a chronic secondary pain condition, which is a consequence of peripheral or central nervous (somatosensory) system lesions or diseases. It is a devastating condition, which affects around 7% of the general population. Numerous etiological factors contribute to the development of chronic neuropathic pain. It can originate from the peripheral part of the nervous system such as in the case of trigeminal or postherpetic neuralgia, peripheral nerve injury, painful polyneuropathies, or radiculopathies. Central chronic neuropathic pain can develop as a result of spinal cord or brain injury, stroke, or multiple sclerosis. As first-line pharmacological treatment options, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, and gabapentinoids are recommended. In trigeminal neuralgia, carbamazepine and oxcarbazepine are the first-choice drugs. In drug-refractory cases, interventional, physical, and psychological therapies are available. This review was structured based on a PubMed search of papers published in the field from 2010 until May 2019.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据